Adage Capital Partners Gp, L.L.C. Eledon Pharmaceuticals, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.02 - $6.07 $1.65 Million - $2.49 Million	-409,759 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.46 $2.63 Million - $3.75 Million	-443,449 Reduced 51.97%	409,759 $2.53 Million
Q2 2021 Aug 16, 2021	SELL	$7.62 - $11.75 $299,824 - $462,327	-39,347 Reduced 4.41%	853,208 $6.75 Million
Q1 2021 May 17, 2021	BUY	$9.85 - $19.22 $8.79 Million - $17.2 Million	892,555 New	892,555 $9.55 Million

18.4M

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $60M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.